Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000904454-17-000137)

Filing Details

Accession Number:: 0000904454-17-000137
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-08 18:40:22
Reporting Period:: 2017-02-06

Filing Date:: 2017-02-08
Accepted Time:: 2017-02-08 18:40:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Paratek Pharmaceuticals Inc.	PRTK	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1628880	W. Douglas Pagan	C/O Paratek Pharmaceuticals, Inc. 75 Park Plaza, 4Th Floor Boston MA 02116	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-02-06	17	$15.20	58,983	No	4	S	Direct
Common Stock	Disposition	2017-02-06	732	$15.15	58,251	No	4	S	Direct
Common Stock	Disposition	2017-02-06	1,428	$15.10	56,823	No	4	S	Direct
Common Stock	Disposition	2017-02-06	17	$15.08	56,806	No	4	S	Direct
Common Stock	Disposition	2017-02-06	1,186	$15.05	55,620	No	4	S	Direct
Common Stock	Disposition	2017-02-06	25	$15.09	55,595	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan.